Found 43 matching trials
the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL) PHASE1 The main purpose of this study is to explore the sequential therapeutic eff...
Show More Location
Southwest Hospital of Third Millitary Medical University
Learn More & Join Trial
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Show More Location
Banner University Medical Center - Tucson
Learn More & Join Trial
Safety of Autologous Humanized Anti-CD19 and Anti-CD20 Dual Specific CAR-T Cells in Adult Patients With Diffuse Large B-cell Lymphoma PHASE1 This is a single-arm, open-label, dose escalation, phase I study, aiming to...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy PHASE3 The goal of this clinical study is to compare the study drug KITE-753 versu...
Show More Location
City of Hope Arizona
Learn More & Join Trial
A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma PHASE1 This is a multicenter, single arm, open-label study. The purpose of the stu...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy EARLY_PHASE1 This is an exploratory trial to evaluate the safety, tolerability, pharmaco...
Show More Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Learn More & Join Trial
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy EARLY_PHASE1 This study is a single-center, open-label clinical trial of single-dose of ...
Show More Location
Affiliated Hospital of Nantong University
Learn More & Join Trial
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy PHASE2 This phase II trial compares epcoritamab to standard practice (observation)...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell PHASE1 This is a phase 1/1b, interventional single arm, open label, treatment stud...
Show More Location
Froedtert Hospital & Medical College of Wisconsin
Learn More & Join Trial
National Project on Vaccines, COVID-19 and Frail Patients N/A This is a multicentre observational study with the aim of evaluating the an...
Show More Location
IRCCS Istituto Tumori Giovanni Paolo II
Learn More & Join Trial